Nightbox LLC Completes In Silico Validation of NKG2D-LIF6 Chimera

In silico package complete: AlphaFold + Rosetta structural validation passed; PK-PD model predicts approximately 99% TGI ceiling on syngeneic CRC models; 1.4 x 10^3 tumor-to-healthy selectivity ratio; freedom-to-operate clean.